The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Open accessAbstract
Background and Purpose— The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial found that treatment with atorvastatin 80 mg per day reduced the risk of stroke and cardiovascular events in patients with a recent transient ischemic attack (TIA) or stroke. We hypothesized this benefit would be greatest in the subgroup of patients with carotid stenosis. Methods— The SPARCL trial randomized patients with TIA or stroke within 1 to 6 months without known coronary heart disease (CHD) and low-density lipoprotein cholesterol 100 to 190 mg/dL to treatment with atorvastatin 80 mg per day or placebo. Investigators identified subjects as having carotid stenosis not requiring revascularization at the time of randomization. Of the total SPARCL population, 1007 were documented as having carotid stenosis at baseline, 3271 did not, and the status of 453 was unknown. Results— We found no heterogeneity in the treatment effect for the SPARCL primary (fatal and nonfatal stroke) and secondary end points between the group with and without carotid stenosis. The group with carotid artery stenosis had greater benefit when all cerebro- and cardiovascular events were combined. In the group with carotid artery stenosis, treatment with atorvastatin was associated with a 33% reduction in the risk of any stroke (hazard ratio [HR] 0.67, 95% confidence interval [CI] 0.47, 0.94; P =0.02), and a 43% reduction in risk of major coronary events (HR 0.57, 95% CI 0.32, 1.00; P =0.05). Later carotid revascularization was reduced by 56% (HR 0.44, 95% CI 0.24, 0.79; P =0.006) in the group randomized to atorvastatin. Conclusion— Consistent with the overall results of the SPARCL intention to treat population, intense lipid lowering with atorvastatin reduced the risk of cerebro- and cardiovascular events in patients with and without carotid stenosis. The carotid stenosis group may have greater benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Endarterectomy for Asymptomatic Carotid Artery Stenosis
Walker, M. D. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420037035 · Cited by 4,403
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
Helgason, C. M., & Wolf, P. A. (1997) · Stroke · doi:10.1161/01.str.28.7.1498 · Cited by 440
Hankey, G. J., Jamrozik, K., Broadhurst, R. J., Forbes, S., Burvill, P. W., Anderson, C. S., & Stewart-Wynne, E. G. (2000) · Stroke · doi:10.1161/01.str.31.9.2080 · Cited by 403
Amarenco, P., Goldstein, L. B., Szarek, M., Sillesen, H., Rudolph, A. E., Callahan, A., Hennerici, M., Simunovic, L., Zivin, J. A., & Welch, K. M. A. (2007) · Stroke · doi:10.1161/strokeaha.107.493106 · Cited by 343
Self-citationHENNERICI, M., HÜLSBÖMER, H.-B., HEFTER, H., LAMMERTS, D., & RAUTENBERG, W. (1987) · Brain · doi:10.1093/brain/110.3.777 · Cited by 312
Self-citationTouboul, P.-J., Elbaz, A., Koller, C., Lucas, C., Adraï, V., Chédru, F., Amarenco, P., & Investigators, F. T. G. (2000) · Circulation · doi:10.1161/01.cir.102.3.313 · Cited by 270
Self-citation(2003) · Cerebrovascular Diseases · doi:10.1159/000072562 · Cited by 184
Gresham, G. E., Alexander, D., Bishop, D. S., Giuliani, C., Goldberg, G., Holland, A., Kelly-Hayes, M., Linn, R. T., Roth, E. J., Stason, W. B., et al. (1997) · Stroke · doi:10.1161/01.str.28.7.1522 · Cited by 174
Autopsy Prevalence of Coronary Atherosclerosis in Patients With Fatal Stroke
Gongora-Rivera, F., Labreuche, J., Jaramillo, A., Steg, P. G., Hauw, J.-J., & Amarenco, P. (2007) · Stroke · doi:10.1161/01.str.0000260091.13729.96 · Cited by 159
Self-citationPanel, Mohr, J. P., Albers, G. W., Amarenco, P., Babikian, V. L., Biller, J., Brey, R. L., Coull, B. M., Easton, J. D., Gomez, C. R., et al. (1997) · Stroke · doi:10.1161/01.str.28.7.1501 · Cited by 96
Self-citationIdentifying patient populations at high risk for stroke
Sacco, R. L. (1998) · Neurology · doi:10.1212/wnl.51.3_suppl_3.s27 · Cited by 62
Cited by
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Endorsed by: the European Stroke Organisation (ESO), Authors/Task Force Members, Tendera, M., Aboyans, V., Bartelink, M.-L., Baumgartner, I., Clément, D., Collet, J.-P., Cremonesi, A., De Carlo, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr211 · Cited by 1,506
Naylor, R., Rantner, B., Ancetti, S., de Borst, G. J., De Carlo, M., Halliday, A., Kakkos, S. K., Markus, H. S., McCabe, D. J. H., Sillesen, H., et al. (2023) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2022.04.011 · Cited by 924
Self-citationAmarenco, P., & Labreuche, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70058-4 · Cited by 660
Self-citationA Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
Amarenco, P., Kim, J. S., Labreuche, J., Charles, H., Abtan, J., Béjot, Y., Cabrejo, L., Cha, J.-K., Ducrocq, G., Giroud, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910355 · Cited by 567
Self-citationMarquardt, L., Geraghty, O. C., Mehta, Z., & Rothwell, P. M. (2010) · Stroke · doi:10.1161/strokeaha.109.561837 · Cited by 454
Metadata
- Authors
- Sillesen, H., Amarenco, P., Hennerici, M. G., Callahan, A., Goldstein, L. B., Zivin, J., Messig, M., & Welch, K. M.
- Venue
- Stroke
- Published
- 2008-12
- Volume
- 39
- Issue
- 12
- Pages
- 3297-3302
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2115619413
- Cited by
- 277
- References
- 18
- FWCI
- 21.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.